{"title":"After COVID-19, LUGPA More Important Than Ever.","authors":"Richard Gerald Harris","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 2","pages":"75-76"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393689/pdf/RiU022002_0075.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38233589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The management of small, non-obstructing renal stones in adults with recurrent lower urinary tract infections remains unclear. Whereas for larger or obstructing stones the decision to intervene becomes clearer, for stones smaller than 5 to 6 mm the decision to intervene requires consideration of multiple factors. This review describes these factors, including history, imaging, laboratory studies, as well as a comprehensive review of the literature. It remains of utmost importance that patients have additional possible etiologies appropriately evaluated and managed prior to intervention for their small renal stones.
{"title":"Management of Small, Non-obstructing Renal Stones in Adults With Recurrent Urinary Tract Infections.","authors":"Ron Golan, Kimberly L Cooper, Ojas Shah","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The management of small, non-obstructing renal stones in adults with recurrent lower urinary tract infections remains unclear. Whereas for larger or obstructing stones the decision to intervene becomes clearer, for stones smaller than 5 to 6 mm the decision to intervene requires consideration of multiple factors. This review describes these factors, including history, imaging, laboratory studies, as well as a comprehensive review of the literature. It remains of utmost importance that patients have additional possible etiologies appropriately evaluated and managed prior to intervention for their small renal stones.</p>","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 2","pages":"52-56"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393687/pdf/RiU022002_0052.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38234625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Primary Retroperitoneal Lymph Node Dissection for Stage IB Nonseminomatous Germ Cell Tumor: NYU Case of the Month, April 2020.","authors":"Richard S Matulewicz","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":" ","pages":"40-42"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265180/pdf/RiU022001_0040.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38031334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non-muscle-invasive Bladder Cancer Management During BCG Shortages: NYU Case of the Month, February 2020.","authors":"LaMont J Barlow","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":" ","pages":"35-36"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265177/pdf/RiU022001_0035.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38031423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Leptomeningeal carcinomatosis is a rare complication of prostate cancer. It is likely underdiagnosed as suggested by autopsy studies and is expected to become more prevalent with increasing survival of prostate cancer patients. Prostate cancer leptomeningeal carcinomatosis is associated with rapid functional decline and a median survival of approximately 1 month. Diagnosis is challenging because the clinical manifestations are varied, and no gold-standard diagnostic approach exists. Treatment of prostate cancer leptomeningeal carcinomatosis is not standardized and multiple approaches have been reported, mostly as case studies. Herein we report a case of a 73-year-old patient with metastatic castration-resistant prostate cancer who presented to our clinic with subacute cognitive decline, ataxia, and urinary incontinence, and was found to have leptomeningeal carcinomatosis.
{"title":"Leptomeningeal Carcinomatosis of Prostate Cancer: A Case Report and Review of the Literature.","authors":"Elad Neeman, Noriko Salamon, Matthew Rettig","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Leptomeningeal carcinomatosis is a rare complication of prostate cancer. It is likely underdiagnosed as suggested by autopsy studies and is expected to become more prevalent with increasing survival of prostate cancer patients. Prostate cancer leptomeningeal carcinomatosis is associated with rapid functional decline and a median survival of approximately 1 month. Diagnosis is challenging because the clinical manifestations are varied, and no gold-standard diagnostic approach exists. Treatment of prostate cancer leptomeningeal carcinomatosis is not standardized and multiple approaches have been reported, mostly as case studies. Herein we report a case of a 73-year-old patient with metastatic castration-resistant prostate cancer who presented to our clinic with subacute cognitive decline, ataxia, and urinary incontinence, and was found to have leptomeningeal carcinomatosis.</p>","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 2","pages":"80-84"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393686/pdf/RiU022002_0080.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38233591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hersh M Trivedi, Nirmish Singla, John Lafin, David Fetzer, Payal Kapur, Aditya Bagrodia
Current guidelines regarding treatment for germ-cell tumors (GCTs) emphasizes cautious progression focusing on stage-specific treatments. Presented herein is the case of a 30-year-old man who, through monitoring of serum alpha-fetoprotein (AFP) levels and surveillance imaging, avoided excessive treatment. This case demonstrates how an experienced clinician, familiar with natural history of GCTs, can appropriately classify level of risk and allow a patient to preserve natural fertility. Furthermore, we highlight the potential for miRNA analysis in staging and management of GCTs. This case serves to underscore the importance of acting with caution in the pursuit of the best outcome for our patients.
{"title":"First Do No Harm: A Cautious, Risk-adapted Approach to Testicular Cancer Patients.","authors":"Hersh M Trivedi, Nirmish Singla, John Lafin, David Fetzer, Payal Kapur, Aditya Bagrodia","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Current guidelines regarding treatment for germ-cell tumors (GCTs) emphasizes cautious progression focusing on stage-specific treatments. Presented herein is the case of a 30-year-old man who, through monitoring of serum alpha-fetoprotein (AFP) levels and surveillance imaging, avoided excessive treatment. This case demonstrates how an experienced clinician, familiar with natural history of GCTs, can appropriately classify level of risk and allow a patient to preserve natural fertility. Furthermore, we highlight the potential for miRNA analysis in staging and management of GCTs. This case serves to underscore the importance of acting with caution in the pursuit of the best outcome for our patients.</p>","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 2","pages":"85-89"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393682/pdf/RiU022002_0085.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38233592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David D Watson, Nicole M Farha, K James Kallail, Shaker Dakhil, A J Farha
Immunotherapy has revolutionized the treatment of metastatic renal cell carcinoma (RCC). This case evaluates the use of neoadjuvant immunotherapy for localized RCC in a patient with solitary functioning kidney. A retrospective chart review was conducted between September 2019 and January 2020 on a single patient. Before treatment, the tumor was 7 cm × 8 cm × 8.5 cm. The patient trialed nivolumab + ipilimumab then cabozantinib. The tumor shrunk to 6.3 cm × 5.5 cm and was removed via partial nephrectomy. This case demonstrates the efficacy of immunotherapy in neoadjuvant treatment of RCC. Expansion of guidelines could allow for patients with RCC to undergo partial nephrectomy.
免疫疗法已经彻底改变了转移性肾细胞癌(RCC)的治疗。本病例评估了新辅助免疫治疗局部肾细胞癌在孤立功能肾患者中的应用。在2019年9月至2020年1月期间，对一名患者进行了回顾性图表审查。治疗前肿瘤大小为7cm × 8cm × 8.5 cm。患者先试验了纳武单抗+伊匹单抗，然后是卡博赞替尼。肿瘤缩小至6.3 cm × 5.5 cm，行部分肾切除术。本病例证明了免疫治疗在RCC新辅助治疗中的有效性。扩大指南可允许肾细胞癌患者接受部分肾切除术。
{"title":"From Radical to Partial Nephrectomy in the Setting of Solitary Functioning Kidney: Neoadjuvant Treatment of Renal Cell Carcinoma.","authors":"David D Watson, Nicole M Farha, K James Kallail, Shaker Dakhil, A J Farha","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Immunotherapy has revolutionized the treatment of metastatic renal cell carcinoma (RCC). This case evaluates the use of neoadjuvant immunotherapy for localized RCC in a patient with solitary functioning kidney. A retrospective chart review was conducted between September 2019 and January 2020 on a single patient. Before treatment, the tumor was 7 cm × 8 cm × 8.5 cm. The patient trialed nivolumab + ipilimumab then cabozantinib. The tumor shrunk to 6.3 cm × 5.5 cm and was removed via partial nephrectomy. This case demonstrates the efficacy of immunotherapy in neoadjuvant treatment of RCC. Expansion of guidelines could allow for patients with RCC to undergo partial nephrectomy.</p>","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 3","pages":"126-129"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672501/pdf/RiU022003_0126.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38306004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Management of Urethral Stenosis After Treatment for Prostate Cancer: NYU Case of the Month, August 2020.","authors":"Lee C Zhao","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 3","pages":"133-134"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672505/pdf/RiU022003_0133.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38306006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Washington Roundup.","authors":"R Jonathan Henderson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 4","pages":"168-169"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058918/pdf/RiU022004_0168.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38865832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Surgical Management of the \"Large\" Prostate: The Robotic Simple Prostatectomy: NYU Case of the Month, October 2020.","authors":"Benjamin M Brucker, Alice Drain","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"22 4","pages":"174-176"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058917/pdf/RiU022004_0174.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38865834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号